Editorial policy

Content is prepared and published by TYZEPA.com. TYZEPA.com is associated with the TYZEPA medicine brand and is not an independent product-review service.

No page should imply independent clinical review unless a qualified reviewer has actually reviewed that version and has consented to public attribution. A reviewer’s name, qualifications and profile should appear only when those details are accurate and verifiable.

For medical and product information, the editorial team prioritizes:

1. current regulator publications and public product records;
2. official prescribing information and patient leaflets for the exact named product;
3. peer-reviewed clinical studies;
4. clinical-trial registry records;
5. established public-health and professional guidance; and
6. manufacturer information for product identity or security checks, clearly identified as manufacturer-provided information.

News reports, pharmacy listings, social-media posts and testimonials are not treated as proof of authorization, product quality, comparative effectiveness or safety.

The site distinguishes evidence about an active ingredient from evidence about a finished branded product.

Mounjaro® and TYZEPA are separate products. Mounjaro or Zepbound studies can provide context about tirzepatide and the products that were actually studied. They do not automatically establish TYZEPA-specific formulation, device accuracy, manufacturing quality, effectiveness, side-effect frequency, regulatory status or interchangeability.

Likewise, a package stating the same active ingredient does not by itself establish that two products are identical or clinically equivalent.

Headings and summaries should accurately reflect the cited evidence and its limits. The site does not publish unsupported claims that TYZEPA is:

• identical or interchangeable with Mounjaro;
• proven safer or more effective than another product;
• automatically higher quality because it is described as imported;
• authorized, registered or lawfully supplied in Pakistan without current product-specific documentation; or
• guaranteed to produce a particular weight, glucose or appearance outcome.

Average clinical-trial results are presented as group findings, not promises for an individual patient.

International labels and trials are used as clinical context. They do not substitute for current Pakistan product information or regulatory records.

Where the exact status of a product, seller, importer, batch or supply route is not established, the page should say so. Readers are directed to current DRAP resources and qualified pharmacists for unresolved product questions.

Safety pages identify the product from which warnings and adverse-effect information are drawn. Emergency warning signs are written plainly, but the site does not provide individualized diagnosis, dosing, stopping instructions or emergency care.

Readers are advised to use the leaflet for the exact product and to seek qualified clinical or emergency help when appropriate.

Every evidence article should display:

• the original publication date;
• the date of the most recent substantive update; and
• a Last fact checked date when the sources and claims have been rechecked.

The label Medically reviewed by should be used only when a qualified clinician has reviewed that exact version and consented to attribution. A generic “Reviewed” label without identifying the review should not be used.

Product information, labels, studies and regulatory records can change. TYZEPA.com reviews material updates when reliable new information becomes available.

A substantive correction should be made in the article, reflected in the modified date and described in a short correction note when it materially changes the reader’s understanding. Spelling or formatting edits do not require a correction note.

To report a possible error, use the official WhatsApp contact path and include the page URL, the exact statement in question, the reason it may be inaccurate and a primary or authoritative source supporting the correction.

No calls — WhatsApp text messages only.

External references should link as directly as possible to the supporting regulator document, prescribing information, study or guidance. A citation indicates the source used; it does not imply that the source organization endorses TYZEPA or TYZEPA.com.

Internal links are used to connect related patient guides. Link wording should describe the destination accurately and should not promise a treatment result.

Illustrations are used to explain concepts or support page design. Illustrative weight-change imagery is not a patient testimonial or a representation of a guaranteed TYZEPA result. Product photographs should be described accurately and should not be treated as proof of authenticity, authorization, quality or storage integrity.

TYZEPA.com is associated with the TYZEPA medicine brand. This relationship is disclosed on educational pages and on the About TYZEPA.com page. The website should not describe itself as an independent review source.

References to Mounjaro, Zepbound, Ozempic, Wegovy, manufacturers, regulators, journals or professional bodies do not imply endorsement of TYZEPA or this website.

The website provides general education. Prescription decisions require an individual assessment, current information for the exact product and follow-up with a qualified clinician. Patients should not start, stop, share or change the dose of a prescription medicine based only on website or social-media content.